FREE BYETTA CASE EVALUATION
NOTE: This Case Evaluation form can also be completed for situations that involve other diabetes medications such as Januvia and/or Victoza -- even in there is no Byetta involved.
Diabetes drugs in the incretin mimetic class -- and their manufacturers --include:
Exenatide (Byetta, Bydureon / injection) -- Amylin, which was acquired by Bristol Myers Squibb (BMS), which co-markets with Astra-Zeneca (AZ);
Liraglutide (Victoza / injection) -- Novo Nordisk;
Sitagliptin (Januvia, Janumet, Janumet XR, Juvisync / tablets) -- Merck;
Saxagliptin (Onglyza, Kombiglyze XR / tablets) -- BMS/AZ;
Alogliptin (Nesina, Kazano, Oseni / tablets) -- Takeda; and,
Linagliptin (Tradjenta, Jentadueto / tablets) -- Boehringer Ingelheim
Please let us know which of these diabetes drugs was being used during the time leading up to side-effect diagnosis in the "additional information" box, below.
Our law firm represents people in personal injury and wrongful death cases that involve serious side effects and adverse reactions which may have been caused by the use of Byetta (exenatide) such as the following:
- Pancreatic Cancer,
or Pancreas Cancer
- Thyroid Cancer
Please be assured that the information you provide to our law firm when completing this legal case evaluation form will be treated by us as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
NOTE: We are no longer taking cases involving:
- Pancreatitis: Acute / Hemorrhagic / Necrotizing
- Kidney Failure
- Renal Insufficiency